(Q24618690)
Statements
Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma (English)
0 references
Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma (English)
1 reference
Amod A. Sarnaik
Stephan Targan
Jeffrey S. Weber
15 February 2011
0 references
24 November 2010
17
0 references
4
0 references
896-906
0 references
1 reference
1 reference